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Abstract
Bone marrow stromal cells are adult multipotent cells that represent an attractive tool in cellular therapy strategies. Several
studies have reported that in vitro passaging of mesenchymal stem cells alters the functional and biological properties of
those cells, leading to the accumulation of genetic aberrations. Recent studies described bone marrow stromal cells (BMSC)
as mixed populations of cells including mesenchymal (MSC) and neural crest stem cells (NCSC). Here, we report the
transformation of NCSC into tumorigenic cells, after in vitro long-term passaging. Indeed, the characterization of 6 neural
crest-derived clones revealed the presence of one tumorigenic clone. Transcriptomic analyses of this clone highlighted,
among others, numerous cell cycle checkpoint modifications and chromosome 11q down-regulation (suggesting a deletion
of chromosome 11q) compared with the other clones. Moreover, unsupervised analysis such as a dendrogram generated
after agglomerative hierarchical clustering comparing several transcriptomic data showed important similarities between
the tumorigenic neural crest-derived clone and mammary tumor cell lines. Altogether, it appeared that NCSC isolated from
adult bone marrow represents a potential danger for cellular therapy, and consequently, we recommend that phenotypic,
functional and genetic assays should be performed on bone marrow mesenchymal and neural crest stem cells before in vivo
use, to demonstrate whether their biological properties, after ex vivo expansion, remain suitable for clinical application.
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Introduction
Although the adult brain contains small numbers of stem cells in
restricted areas, the central nervous system exhibits limited
capacity of regenerating lost tissue. Therefore, cell replacement
therapies of damaged brain have provided the basis for the
development of potentially powerful new therapeutic strategies for
a broad spectrum of human neurological diseases. In recent years,
neurons and glial cells have been successfully generated from
embryonic stem cells [1], induced pluripotent stem cells [2],
mesenchymal stem cells [3–4], and adult neural stem cells [5].
There have also been extensive efforts made by researchers to
develop stem cell-based brain transplantation therapies. The
generation of neural cells from bone marrow is of important
clinical interest as, beside the unlimited number of cells, those cells
would allow autologous grafts. In the meantime, multipotent
neural crest stem cells were discovered as a minor population of
bone marrow cells [6]. The potential impact of those cells in
regenerative medicine is significant [7], however, it is important to
further characterize those cells with extensive proliferation both in
vivo and in vitro. Indeed, recent studies report the contribution of
BMSC in cancer formation and their possible capacity for
spontaneous immortalization under long term in vitro culturing
[8–10]. Moreover, as only a few NCSC are available in adult bone
marrow, several passages are necessary to obtain a sufficient
amount of cells [11].
To characterize the NCSC present in bone marrow, we isolated
and cultivated 6 neural crest derived clones. These clones were
first characterized in vitro, then, were injected into mice striatum to
analyze their ability to survive and differentiate in vivo. One of
those clones (Asclepios) had the highest ability to differentiate into
neuronal cells (in vitro), and also showed a very high rate of
proliferation after injection into mice striatum, when compared to
the other clones. We therefore hypothesized that this abnormal
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proliferation was the result of the evolution of Asclepios into a
tumoral clone.
To evaluate the tumorigenic potential of the Asclepios clone, we
performed a whole genome mRNA expression assay on non-
injected cells. We compared Asclepios to its direct NCSC reference
(Mix of 5 NCSC clones), as well as to several tumor cell types and
highlighted numerous similarities between the Asclepios clone and
mammary tumor types. Additionally, we observed a deep
modification of the cell cycle checkpoints in the Asclepios clone
that may lead to uncontrolled proliferation. Likewise, chromo-
somal patterns of mRNA expression levels revealed blocks of
differentially expressed chromosomal regions with a striking down
regulation of the major part of the chromosome 11. Altogether,
this report strongly highlights the prudence that should be taken in
cellular therapy protocols when using adult bone marrow NCSC
as previously suggested for MSC.
Materials and Methods
Animal care
Wnt1-Cre/R26R-LACZ double transgenic mice were used to
confirm the presence of neural crest cells in adult bone marrow
and to discriminate NCSC clones. Transgenic green fluorescent
protein (GFP) C57BL/6J mice (The Jackson Laboratory, Bar
Harbor, Maine) were used to produce cerebellar granule neurons
(CGN) cultures. Likewise, wild type C57BL/6J mice (The Jackson
Laboratory) were used as recipient mice for graft experiments.
Rodents were bred at the University of Lie`ge Central Animal
facility and euthanized in accordance with the rules set by the local
animal ethics committee as well as the Swiss Academy of Medical
Sciences.
Intrastriatal grafts
Animals were anesthetized with 100 mg/kg of a solution
containing equal volumes of xylazine (Rompun) and ketamine
(Ketalar). Mice were then placed into a stereotaxic frame
(Benchmark, MyNeuroLab.com) and received one injection of
56104 cells suspended in 2 mL PBS (GIBCO, Invitrogen) in the
right striatum (0,5 mm anterior, 2 mm lateral and 3 mm ventral,
with respect to bregma). The intracerebral injection was
performed using a Hamilton’s 5 ml syringe, coupled with a 26-
gauge needle. The needle was left in place for few minutes before
being retracted, to avoid reflux along the injection track. After the
operation, mice were placed under a warm lamp until their
complete awakening.
Brain processing
28 days after the cell transplantation, animals were deeply
anesthetized and sacrificed by intracardiac perfusion of cold PBS,
followed by paraformaldehyde (PFA) 4% (in 0,1 M PBS). Brains
were immediately removed, post-fixed for 2 hours at 4uC in the
same fixative and immersed overnight in a solution of sucrose 20%
(in 0,1 M PBS). They were then rapidly frozen in isopentane and
stored at 220uC. Coronal 14 mm-sections (containing the entirety
of the striatum) were cut using a cryostat and mounted on
positively charged slides and stored in 280uC for further
experiments.
Bone marrow stromal cell (BMSC) culture
Bone marrow cells from adult (8–10 week-old) mice were
obtained from femoral and tibial bones by aspiration and were
resuspended in 5 ml of MesenCult Medium (StemCells Technol-
ogies). After 24 hours, non-adherent cells were removed. When
the BMSC became confluent, they were resuspended using 0.05%
trypsin-EDTA (Invitrogen) and then cultured (750,000 cells/
25 cm2).
Preparation and culture of Mouse cerebellar granule
neurons
Mouse cerebellar granule neuron (CGN) cultures were prepared
from 3-day-old GFP or wild type C57BL/6J mice (The Jackson
Laboratory) [3]. Green mice express green fluorescent protein
(GFP) under control of the beta-actin promoter [3]. Briefly,
cerebella were removed and freed of meninges. They were then
minced into small fragments and incubated at 37uC for
25 minutes in 0.25% trypsin and 0.01% DNAse (w/v, in a
cation-free solution). Fragments were then washed with minimum
essential medium (Invitrogen) supplemented with glucose (final
concentration 6 g 121), insulin (Sigma-Aldrich; 5 mg ml21) and
pyruvate (Invitrogen; 1 mM). The potassium concentration was
increased to 25 mM, while the sodium concentration was
decreased in an equimolar amount (MEM-25HS). The dissocia-
tion was achieved mechanically by up-and-down aspirations in a
5-ml plastic pipette. The resulting cell suspension was then filtered
on a 15-mm nylon sieve. Cells were then counted and diluted to a
final concentration of 2.56106 ml21. The cell suspension was
finally plated on a substrate previously coated with polyornithine
(0.1 mg ml21). The cells were cultured for 24 hours before any
other experimental procedure was performed.
Clonal selection
Passage 5 BMSC (from Wnt1-Cre/R26R-LACZ double trans-
genic mice) have been seeded in a 96 well plate (Nunc) at a dilution
of 0.7 cell/well, in MesenCult Medium (Stem Cells Technologies).
When cells reached confluence, they were dissociated with
Trypsin-EDTA (0.05%) and cultured at 150,000 cells/ml.
Immunofluorescence
Briefly, cell cultures were fixed with 4% PFA for 10 min at
room temperature, then blocked with 10% normal donkey serum
(NDS) for 45 min. Anti-Sox10 (1:200; Affinity Bioreagents), anti-
nestin (1:300; Novus Biologicals), anti-betaIII-tubulin (1:1000;
Covance), anti-p75NTR (1:100; Millipore), anti-NrCAM (1:400;
Abcam), anti-N-Cadherin (1:500, BD-Biosciences) and anti-E-
Cadherin (1:400, BD-Biosciences) were used overnight at 4uC.
After four washes, cell cultures were incubated with FITC- or
rhodamine-conjugated secondary antibodies (1:500; Jackson Im-
munoresearch Laboratories) for 1 h at room temperature and
finally, and finally mounted in Vectashield HardSet Mounting
Medium with DAPI (Vector Laboratories). Preparations were
observed using a Nikon TE 2000-U epifluorescent microscope
(Nikon, Amstelveen, The Netherlands) or an Olympus laser
scanning confocal microscope (Olympus, Tokyo, Japan). The
digitized images were adjusted for brightness and contrast, color-
coded, and merged, when appropriate, using the NIH program
ImageJ or the Adobe Photoshop 6.0 program (Adobe Systems
Incorporated, San Jose, CA). The fraction of positive cells was
determined by analyzing 10 non-overlapping fields for each
coverslip (with a minimum of 3 coverslips per experiment) in at
least three separate experiments (n represents the number of
experiments).
Other Stainings
X-gal staining was performed on 2% PFA-fixed cells and on
striatum slices (14 mm). Cells and sections were incubated for
2 hours in PBS supplemented with Tris (pH 7,4) 20 mM, MgCl2
2 mM, 0.02% NP-40, 0.01% Na-deoxycholate, K3Fe(CN)6 5 mM
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(Sigma-Aldrich), K4Fe(CN)6 5 mM (Sigma-Aldrich) and 1-Methyl-
3-indolyl-beta-D-galactopyranoside 1 mg/ml (Sigma–Aldrich) in
DMSO. The reaction was stopped by PBS washes. Hematoxylin/
eosin coloration. Dry brain sections were placed in denatured
ethanol and slightly heated for approximately 4 minutes, then
were washed three times in milliQ water, before an incubation of
10 minutes in Carazzi hematoxylin. After three washes in water,
sections were incubated for 2 minutes in eosin. Once colored,
sections were washed again in milliQ water for three times,
dehydrated in successive alcohol solutions and finally mounted
with Q Path Safemount (Labonord).
Cell Proliferation Assay
Cell proliferation assay was performed using tetrazolium
compound based CellTiter 96H AQueous One Solution Cell
Proliferation (MTS) assay (Promega). 56103 cells of each NCSC
clone were seeded into wells of a 96-well plate. After 24 and
48 hours of culture under regular growth conditions (Mesencult
medium), MTS assay was performed according to the manufac-
turer’s instructions. Each experience was performed in triplicate
and repeated 3 times (n = 3).
Figure 1. Phenotypic characterization of neural-crest derived cells isolated from adult bone marrow. Neural crest stem cells were
isolated from double transgenic Wnt1/Cre-R26R/LacZ mice and cultured under clonal conditions. A–B. Neural crest derived clones were
morphologically similar to classical BMSC. As clones have been isolated from double transgenic mice Wnt1-CRE/R26R-LacZ, neural crest-derived cells
are expressing beta-galactosidase, visualized after an X-gal staining (A). C–L. Immunological characterization revealed that neural crest derived cells
were nestin (C), P75NTR (D), Sox10 (E), CD9 (F), MMP12 (G), CDH13 (H), CD82 (I) positives, but CD24 (J), CD38 (K) and MMP13 (L) negatives. M–N. A
percentage of neural crest stem cells were able to differentiate into beta-III-tubulin-positive cells when co-cultivated with GFP-positive cerebellar
granule neurons (M), however, Asclepios showed a higher percentage of positive cells as 50.25%61.70% of cells were beta-III-tubulin-positive, when
around 15% of cells were observed with the other clones (N) (mean6 SEM, n=3, p,0.001, ANOVA followed by Bonferroni post hoc test). Nuclei were
counterstained with Dapi (blue) on panels C to N. Scale bars = 30 mm.
doi:10.1371/journal.pone.0046425.g001
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RNA extraction, quality control and microarray
experiments
Total RNA was prepared using the RNeasy total RNA
purification kit (Qiagen) [11]. RNA quality was assessed by the
Experion automated electrophoresis system using the RNA
StdSens Analysis Kit (Bio-Rad). Four micrograms of total RNA
were labeled using the GeneChip Expression 39-Amplification
One-Cycle Target Labeling Kit (Affymetrix) following the
manufacturer’s protocol. The cRNA was hybridized to GeneChip
Mouse Genome 430 2.0 (Affymetrix) according to the manufac-
turer’s protocol. Briefly, double-stranded cDNA was synthesized
from 4 mg of total RNA primed with a poly-(dT)-T7 oligonucle-
otide. The cDNA was used in an in vitro transcription reaction in
the presence of T7 RNA polymerase and biotin-labeled modified
nucleotides for 16 h at 37uC. Biotinylated cRNA was purified and
then fragmented (35–200 nucleotides) together with hybridization
controls and hybridized to the microarrays for 16 h at 45uC. Using
Fluidics Station (Affymetrix), the hybridized biotin-labeled cRNA
was revealed by successive reactions with streptavidin R-phyco-
erythrin conjugate, biotinylated anti-streptavidin antibody and
streptavidin R-phycoerythrin conjugate. The arrays were finally
scanned with an Affymetrix/Hewlett-Packard GeneChip Scanner
3000 7G. The data were generated with the PLIER algorithm
included in Affymetrix GeneChip Command Console Software
(AGCC) and Expression Console.
Microarray normalization and data filtering
Microarray normalization and data filtering were performed
using BRB-ArrayTools software version 3.8.1 developed by Dr.
Richard Simons and the BRB-ArrayTools Development Team,
http://linus.nci.nih.gov./BRB-ArrayTools.html. We used the
GCRMA algorithm as normalization step. Quartiles of each
expression array were compared in a boxplot view. Medians, first
and third quartiles were similar in each case (data not shown). This
similarity allowed the comparison of the arrays under the same
analysis process. Background noise has been removed with the
‘‘Log Intensity variation’’ function of ‘‘BRB-ArrayTools’’ at a p-
value.0.05.
Chromowave analysis of expression pattern
Spatial expression patterns were investigated using Chromo-
wave [12] written in MATLAB 6.5 (The Mathworks Inc., Natick
MA, USA). Briefly, mRNA expression values were log2 trans-
formed and mapped to their corresponding chromosomal location
using information from the Affymetrix NetAffx file for the
MOE430_2 array. The mRNA expression values were then
transformed into wavelet coefficients using the Haar wavelet
transform. The wavelet transform is an orthogonal mathematical
operator, with identical noise levels in the original data and at all
wavelet levels. Wavelet coefficients are functions of the difference
in expression of adjacent genes or clusters of genes. Clusters of
genes with similar expression are therefore transformed into a
wavelet coefficient whose the size depends on the number of genes
represented in the cluster. Consequently, individual genes with
expression below the noise level are identified when clustered
together, but undetectable individually. For the Chromowave
pattern analysis, singular value decomposition (SVD) was applied
to the wavelet coefficients from all chromosomes. The profile
Figure 2. In vivo characterization of neural crest derived cells. To characterize neural crest-derived clones in vivo, we stereotaxically injected
50,000 cells of each NCSC clones (separetly) in mice striatum (A). Asclepios induced massive tumors after 4 weeks as attested by the beta-
galactosidase expression of the tumor cells. (B). Immunological characterization of those tumors revealed that they were GFAP (c), beta-III-tubulin
(D), nestin (E), N-cadherin (F) and NrCAM-positive (G). Lectin labeling (H) confirmed the presence of blood vessels in the tumors. Finally, no vimentin
(I) or Sox2 (J) expressions were observed. Nuclei were counterstained with Dapi (blue). Scale bars = 50 mm.
doi:10.1371/journal.pone.0046425.g002
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associated with the case loadings was filtered using a conservative
threshold that accounted for statistical noise, the number of
wavelets and the probe–probe genomic distance, with the
contribution of individual probes zeroed to only allow spatially
extended patterns. After filtering, the remaining coefficients had
the inverse wavelet transform applied to produce a spatial
expression pattern for each chromosome associated with the
primary genome-wide pattern of variations. Case loadings were
analyzed using t-tests to verify the association with groupings. The
P-values were then corrected for the number of multiple
comparisons using the false discovery rate criterion fixed at 5%.
For the cluster analysis the case loadings from the 3 first
eigenvectors were calculated by applying SVD to all wavelet
coefficients from all chromosomes.
Class comparisons and pathway analysis
Class comparisons between Asclepios and NCSC clones were
performed using BRB-ArrayTools with a significance threshold of
0.001, random variance and 10,000 permutations for univariate
tests. The chromosome distribution was performed using BRB-
ArrayTools and compares the percentage of genes for each
chromosome between the 19,667 filtered genes and the 1,544
differentially expressed genes. To determine which pathways were
significantly regulated, the 1,544 differentially expressed genes
were uploaded into Ingenuity Pathway Analysis software (IPA 6.0;
Ingenuity Systems).
Hierarchical clustering
Clustering was generated in an unsupervised analysis after
background noise filtering. This hierarchical cluster compares
expression array data with several expression array data available
from the Gene Expression Omnibus database (GEO) http://www.
ncbi.nlm.nih.gov/geo/. All samples from GEO datasets have been
processed on Affymetrix Mouse Genome Expression Set 430
GeneChips. The package ‘‘pvclust’’ [13] from R-cran [14] was
used on the remaining filtered genes to build and test the
architecture of each cluster of samples. ‘‘pvclust’’ is used for
assessing the uncertainty in hierarchical cluster analysis. For each
cluster in hierarchical clustering, p-values are calculated via
multiscale bootstrap resampling. This indicates how strong the
cluster is supported by data. ‘‘pvclust’’ provides two types of p-
values: AU (Approximately Unbiased) p-value in red and BP
(Bootstrap Probability) value in green. AU p-value, which is
computed by multiscale bootstrap resampling, is a better
approximation to unbiased p-value than BP value computed by
normal bootstrap resampling. We choose the most commonly used
‘‘Euclidean distance’’ as dissimilarity metric and 3 different
methods of linkage (single, complete, average) to obtain dendro-
gram structures. The relevance of dendrograms architecture was
then tested by data permutations. We set the multiscale boostrap
resampling argument of ‘‘pvclust’’ at 10,000 permutations of genes
to test those dendrograms. Only the ‘‘complete linkage’’ method
showed the best stable structure. Microarray results from Asclepios
and NCSC clones are accessible on GEO datasets/NCBI (http://
www.ncbi.nlm.nih.gov/gds).
Figure 3. Clusters based on wavelet coefficients. The first, second and third components are represented in figure A, B and C respectively and
summarized on figure D. These components respectively explain 61.2, 22.7 and 5.9% of the variance of the dataset. For each component, samples in
the same orientation over the y-axis are clustered together. Asclepios (Asc); Neural Crest Stem Cells mix (NCSC); Tumor cell lines 67NR, 66cl4 and 4T1
(TCL, GSE11259); Neural Precursor From Embryonic Stem Cells (NPFES, GSE8024) are represented in these clusters. The difference between Asclepios
and NCSC represents only 5.9% of the variance, making NCSC the best reference to study Asclepios mRNA expression.
doi:10.1371/journal.pone.0046425.g003
Figure 4. Chromosomal distribution of Asclepios genes. Barplot comparing the chromosomal distribution of the differentially expressed genes
(p-value,0.001–1,544 probesets) in blue to the overall background filtered dataset (19,667 probesets) in red. This barplot, based on the comparison
between Asclepios and NCSCs, highlights the chromosome 11 enrichment after statistical univariate tests.
doi:10.1371/journal.pone.0046425.g004
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Results
1. Isolation and characterization of neural-crest derived
clones from adult bone marrow
Since 2008, several studies reported the presence of NCSC in
adult bone marrow [6–7,11]. We cultured BMSC from adult
Wnt1-cre/R26R-LacZ mice under clonal conditions to selectively
isolate NCSC-derived clones. After 5 passages, BMSC were placed
in 96 well plates at a density of 0.7 cells per well. Around 2% of
cells were able to proliferate under those conditions and 6 neural
crest derived clones were maintained for further characterization.
NCSC were discriminated among other cells as they expressed
beta-galactosidase (Fig. 1A). NCSC were morphologically similar
to classical bone marrow mesenchymal cells (Fig. 1B). As no
specific neural crest markers have been described so far to
discriminate NCSC from MSC, we used a panel of markers to
characterize those cells. As observed on Figure 1, NCSC clones
were nestin+ (Fig. 1C), P75NTR+ (Fig. 1D), Sox10+ (Fig. 1E),
CD9+ (Fig. 1F), MMP12+ (Fig. 1G), CDH13+ (Fig. 1H), and
CD82+ (Fig. 1I), but CD242 (Fig. 1J), CD382 (Fig. 1K) and
MMP132 (Fig. 1L).
2. In vitro characterization of NCSC neuronal
differentiating capacities
As one of our interests to isolate NCSC from adult bone marrow
was their potential use in brain regenerative medicine, we decided
first to characterize their ability to differentiate into neurons when
co-cultivated with cerebellar granule neurons (CGN), as previously
described in Wislet-Gendebien et al. [3,7]. Consequently, we co-
cultivated each clone with GFP-positive CGN. As observed on
Figure 1. (M–N), different proportions of beta-III-tubulin-positive
cells were obtained from clones: NCSC1 (referenced as Asclepios):
50.25%61.70%; NCSC2: 8.68%61.94%; NCSC3:
11.80%61.31%; NCSC4: 22.82%63.54%; NCSC5:
10.59%60.95% and NCSC6: 11.29%61.55% of beta-III-tubu-
lin-positive cells, suggesting that some subgroups may exist among
NCSC clones (n=3, p,0.001), ANOVA followed by Bonferroni
post hoc test).
3. Asclepios induces tumor formation when injected into
mouse striatum
As all clones were able to differentiate into beta-III-tubulin-
positive cells, we decided to investigate their ability to differentiate
into neurons and survive when injected into adult mouse striatum.
Therefore, 50,000 cells were stereotaxically injected into the right
striatum (coordinate 0.5 mm before bregma, 2 mm right, 3 mm
deep, Fig. 2A) of healthy mice. Surprisingly, Asclepios induced
massive tumors after 4 weeks (Fig. 2B), whereas really few cells
remained after injection of the other clones (data not shown).
Immunohistological analysis of the tumors revealed the presence
of GFAP (Fig. 2C), beta-III-tubulin (Fig. 2D), nestin (Fig. 2E), N-
cadherin (Fig. 2F) and NrCAM positive cells (Fig. 2G). However,
no vimentin (found in glial-derived tumors- Fig. 2I), or Sox2
positive cells (embryonic stem cell marker expressed in several
brain tumors - Fig. 2J) were observed. Moreover, labeling tumor
sections with lectin (which binds oligosaccharides on the mem-
brane of endothelial cells) specifically revealed a positive staining
within the tumor mass, therefore indicating a vascularization of
the tumors (Fig. 2H).
4. Validation of NCSC mix as a reference for Asclepios
analyses
To understand the molecular basis of the tumorigenic properties
of Asclepios, we decided to compare the gene expression profile of
Asclepios with the one of a reference clone, which did not show
aberrant proliferation and tumorigenic properties. As all of our
NCSC clones share the same origin (from adult BM), as well as the
same immunological and functional characteristics (except Ascle-
Figure 5. Chromowave profile of Asclepios, displays the first eigenvector that explains 84% of the variance between Asclepios and
NCSC mix. Each chromosomal signal has been wavelet transformed. Under and over expressions are respectively below or above 0 on the y-axis.
The x-axis displays the chromosomal position labeled with cytoband names. A large part of the chromosome 11 is under expressed in Asclepios.
doi:10.1371/journal.pone.0046425.g005
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pios), we decided to use a mix of NCSC2, NCSC3, NCSC4,
NCSC5 and NCSC6 clones as a reference. To validate this set as a
suitable reference, we first compared Microarray data from
Asclepios and NCSC to the expression profile of other cell types
selected from GEO database (Tumor Cell Line (TCL) -GSE11259
and Neural Precursor From Embryonic Stem cells (NPFES) -
GSE8024). We analyzed the deep variation of mRNA expression
levels for these datasets. Using CHROMOWAVE software, the
three first eigenvector components were analyzed and 61.2% of
the global variance was explained by the difference between TCL
and the rest (Fig. 3A and 3D), 22.7% of the global variance was
explained by the difference between NPFES and the rest (Fig. 3B
and 3D), and only 5.9% of the global variance was explained by
the difference between Asclepios and NCSC (Fig. 3C and 3D).
These results highlighted the genetic similarities between Asclepios
and NCSC clones, making the NCSC mix a good reference to
study Asclepios.
5. Chromosome 11 as one of the major modifications in
Asclepios
To assess whether the malignant transformation of Asclepios is
associated with the deregulation of a particular chromosome, we
performed an mRNA expression microarray comparison between
Asclepios and the NCSC mix. The class comparison revealed 1,544
differentially expressed genes (p-value,0.001, supplementary data
- Table S1). Interestingly, an enrichment of chromosome 11 genes
was observed in these 1,544 relevant genes compared to the
19,667 genes from the background-filtering step (Fig. 4). To
further identify the spatial level of expression of the chromosome
11 genes, a chromosomal pattern was generated with CHRO-
MOWAVE. Eigenvectors were computed and 84% of the
variance of the dataset was explained by the first component.
The expression pattern of this component is shown in figure 5.
Table 1. Gene type expression on chromosome 11.




Cancer solid tumor 4.74E218
Cancer carcinoma 1.13E217
Cancer digestive organ tumor 2.21E211
Cancer gastrointestinal tract cancer 6.86E210
Cancer breast cancer 2.64E209
Cancer cell transformation 6.30E209
Cancer mammary tumor 1.19E208
Cancer colorectal tumor 1.59E208
Cancer transformation 2.10E208
Cancer colorectal cancer 2.29E208
Cancer hematological neoplasia 3.64E207
Cancer head and neck cancer 9.95E207
Cancer genital tumor 1.28E206
Cancer prostate cancer 1.71E206
Cancer prostatic tumor 2.58E206
Cancer metastasis 3.85E206
Cancer malignant glioma 4.29E206
Cancer tumorigenesis of malignant tumor 7.33E206
Cancer transformation of fibroblast cell lines 9.45E206
Cancer glioblastoma 1.08E205
Cancer glioma 1.17E205
Cancer tumorigenesis of tumor cell lines 1.46E205
Cancer neuroepithelial tumor 2.19E205
Cancer astrocytoma 3.06E205
Cancer central nervous system tumor 3.49E205
Cancer hematologic cancer 4.30E205
Cancer liver tumor 6.91E205
Cancer tumorigenesis of cells 9.26E205
Cancer tumorigenesis of blood tumor 1.26E204
Cancer endocrine gland tumor 1.34E204
Cancer liver cancer 1.36E204
Cancer tumorigenesis of lymphoma 1.73E204
Cancer benign tumor 2.10E204
Cancer thyroid cancer 2.22E204
Cancer brain cancer 2.45E204
Cancer metastatic colorectal cancer 3.77E204
Cancer transformation of fibroblasts 3.96E204
Cancer melanoma 5.26E204
Cancer carcinoma in situ 5.75E204
Cancer lymphoid cancer 6.21E204
Cancer renal cancer 7.97E204
Cancer uterine cancer 8.33E204
Cancer leukemia 8.88E204
Cancer renal tumor 1.11E203
Cancer tumorigenesis of carcinoma 1.33E203
Cancer tumorigenesis of digestive organ tumor 1.40E203
Cancer polycystic ovary syndrome 1.56E203
Table 1. Cont.
Category Functions Annotation p-Value
Cancer lung tumor 2.53E203
Cancer myeloid leukemia 2.62E203
Cancer leiomyomatosis 2.69E203
Cancer plasma cell dyscrasia 2.78E203
Cancer stomach tumor 2.78E203
Cancer ductal carcinoma 3.00E203
Cancer infection of tumor cell lines 3.01E203
Cancer cancer of organ 3.12E203
Cancer metastasis of tumor 3.14E203
Cancer colon cancer 4.39E203
Cancer colon tumor 4.61E203
Cancer infection of cervical cancer cell lines 4.87E203
Cancer lung cancer 5.17E203
Cancer malignant lymphocytic neoplasm 5.28E203
Cancer lymphomagenesis 5.60E203
Cancer pancreatic tumor 5.65E203
Pathway analysis was performed on chromosome 11 genes (probe-sets), using
Ingenuity Pathway Analysis (IPA) and without considering the expression levels
from our data. As shown, chromosome 11 genes are strongly involved in cancer
functions (p-value = 1e223) such as neoplasia (p-value = 1e223) or tumorigenesis
(p-value = 3.3e223).
doi:10.1371/journal.pone.0046425.t001
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Surprisingly, the major part of chromosome 11 showed a low level
of expression in Asclepios. Even if the chromosome 11 deletion is
well described in several cancers [15–18], its genes may be
involved in many biological functions. Therefore, an independent
pathway analysis was performed using Ingenuity Pathway Analysis
(IPA), taking all chromosome 11 genes (probe-sets) extracted from
the UCSC genome browser [19] and without considering the
expression levels from our data. Interestingly, chromosome 11
genes are strongly involved in cancer functions (p-value = 1e223)
such as neoplasia (p-value = 1e223) or tumorigenesis (p-va-
lue = 3.3e223) as described in Table 1. Nevertheless, only a part
of the chromosome 11 genes are relevant (p-value,0.001) in our
study. Therefore, the same analysis was performed based on the
165 significant genes of the chromosome 11 that are differentially
expressed in Asclepios (p-value,0.001) compared to the NCSC
mix. These genes are involved in cancer functions (p-
value = 1.5e24) and also in the cancer signaling pathway PI3K/
AKT (p-value = 3.06e23). Combined together, these results
highlight the importance of the instability of the chromosome 11
in tumorigenesis and explain a lot about the aberrant expansion of
Asclepios in mouse striatum.
6. Significant genes revealed the tumor phenotype of
Asclepios
Even if the low level of expression of many genes located on the
chromosome 11 could mainly explain the tumor profile of Asclepios,
we decided to analyze differentially expressed genes located on all
chromosomes when comparing the gene expression profiles from
Figure 6. Cell cycle: G1/S checkpoints. G1/S checkpoints regulation pathway highlights regulated genes in the comparison between Asclepios
and NCSC mix. Red genes are over-expressed and Green genes are down-expressed in Asclepios. Fold changes from the comparison are written for
single (non complex) genes. This pathway was build with Ingenuity Pathway Analysis software. Major tumor suppressors are down regulated
suggesting a high proliferation of Asclepios cells.
doi:10.1371/journal.pone.0046425.g006
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Asclepios and the NCSC mix. Indeed, few portions of chromosome
7, 9, 10, 12, 13, 14, 17 and 18 were also differentially expressed in
Asclepios (Fig. 5). Therefore, the 1,544 significant genes obtained
with the class comparison were introduced in IPA for biological
functions and pathway analyses. The results confirmed the tumor
profile of Asclepios, as genes associated with cancer functions such
as neoplasia and tumorigenesis (Table 2) and cell death showed
altered expression in this clone. Moreover, many biological
pathways involved in cancer where highlighted. Among them,
PI3K/AKT signaling and PTEN signaling pathways as well as cell
cycle-related proteins regulating the G1/G checkpoint (Fig. 6).
Important tumor suppressor genes are significantly down regulat-
ed in Asclepios (p-value,0.001). p21cip1 is for instance down-
regulated 11.9 fold, NRG1, 9.1 fold and p15, 4 fold. The tumor
suppressor down-regulations strongly suggest an aberrant cellular
proliferation of Asclepios, similar to tumor growth. To validate this
hypothesis, we compared Asclepios cell proliferation with other
clones using MTS assay. MTS colorimetric assay is based on the
reduction of MTS tetrazolium salt into formazan by intracellular
dehydrogenases enzymes found in metabolically active cells. The
quantity of produced formazan as measured by 490 nm absor-
bance is directly proportional to the number of living cells in
culture. As showed in the Figure 7, no difference in cell number is
observed between any NCSC clones after 24 hours of culture.
Conversely, after 48 hours, a highly significant increase in
absorbance is detected for Asclepios in comparison with the
clones NCSC2 to 6 (p,0,001; repeated measures ANOVA,
followed by Tuckey post-test), reflecting an elevated number of
cells in the wells and a higher proliferation rate in an interval of
48 hours.
7. Asclepios comparison with other cell types including
tumor cell lines
As chromosome 11 deletions are involved in several cancers
including breast cancer [15–18], we compared the Asclepios
transcriptome to several cancer cell lines. Normalized Microarray
data from several tumor cell lines, obtained from GEO database,
Figure 7. MTS Cell Proliferation Assay. Cell proliferation assay was
performed using tetrazolium compound based CellTiter 96H AQueous
One Solution Cell Proliferation (MTS) assay (Promega). 56103 cells of
each NCSC clone were seeded into wells of a 96-well plate. After 24 and
48 hours of culture under regular growth conditions (Mesencult
medium), MTS assay was performed according to the manufacturer’s
instructions. Each experience was performed in triplicate and repeated
3 times (n = 3). No difference was observed after 24 hours of culture,
however, a highly significant increase in absorbance was detected for
Asclepios in comparison with the other clones (p,0,001; repeated
measures ANOVA, followed by Tuckey post-test), reflecting a higher
proliferation rate in an interval of 48 hours.
doi:10.1371/journal.pone.0046425.g007
Table 2. Cancer is one of the main biological function hit of
Asclepios.
Category Functions Annotation p-Value Regulation z-score
Cancer tumorigenesis 4.56E220 0.517
Cancer neoplasia 1.58E219 0.596
Cancer cancer 3.29E219 0.508
Cancer carcinoma 1.06E213 20.154
Cancer solid tumor 1.16E213 20.197
Cancer transformation 5.94E212 20.425
Cancer cell transformation 9.26E212 20.326
Cancer digestive organ tumor 2.06E209 21.266
Cancer metastasis 6.27E209 1.970
Cancer transformation of fibroblast cell lines 1.17E208 0.390
Cancer hematologic cancer 2.21E208 21.161
Cancer benign tumor 2.32E208 20.468
Cancer uterine cancer 2.90E208
Cancer gastrointestinal tract cancer 5.65E208
Cancer hematological neoplasia 9.30E208 20.684
Cancer colorectal tumor 1.09E207
Cancer genital tumor 1.23E207 1.415
Cancer colorectal cancer 1.59E207
Cancer Waldenstrom’s macroglobulinemia 1.62E207
Cancer head and neck cancer 3.54E207 0.903
Cancer lung cancer 7.52E207
Cancer lung tumor 1.12E206 20.416
Cancer non-small cell lung cancer 1.62E206
Cancer leukemia 3.94E206 21.340
Cancer plasma cell dyscrasia 3.97E206
Cancer prostatic tumor 4.05E206 1.398
Cancer leiomyomatosis 9.21E206
Cancer mammary tumor 9.81E206 0.075
Cancer central nervous system tumor 2.49E205 0.585
Cancer uterine leiomyoma 3.99E205
Cancer breast cancer 4.69E205
Cancer prostate cancer 5.48E205 1.107
Cancer pancreatic tumor 6.34E205
Cancer brain cancer 7.46E205 0.585
Cancer metastatic colorectal cancer 8.40E205
Cancer glioma 9.23E205 0.646
Cancer infection of tumor cell lines 1.69E204 0.683
Cancer transformation of fibroblasts 2.04E204 0.128
Cancer adenocarcinoma 2.56E204
Cancer endocrine gland tumor 4.43E204
Cancer metastasis of mammary tumor 5.52E204 1.041
Cancer infection of hepatoma cell lines 6.18E204 0.849
Cancer colon tumor 6.79E204
Cancer myeloproliferative disorder 8.45E204
Cancer colon cancer 8.82E204
Cancer tumorigenesis of fibrosarcoma 9.13E204
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were first organized as clusters using a hierarchical clustering
method. The hierarchical clusters were generated, from small
clusters of very similar items to large clusters that include more
dissimilar items resulting in a dendrogram (Fig. 8). In this study,
we compared Asclepios to spontaneous epithelial mammary tumor
cell lines (SEMTCL - GSE13259), tumor cell lines 67NR, 66cl4
and 4T1 (TCL67NR, TCL66cl4 and TCL4T1 - GSE11259),
tumors deriving from neural crest cells (NCCE85, NCCE135,
NCCP90 - GSE11356), multipotent adult progenitor cells (MAPC
- GSE6291); developing heart (DH - GSE7196), neural precursors
obtained from embryonic stem cells (NPFES - GSE8024), white
and brown adipose tissue (WAA, BAA - GSE8044), head neck
neural crest stem cells (E115FAKCtle1 - GSE11149) and murine
acute myeloid leukemia (UAML - GSE30747). As observed on
Figure 7, Asclepios shared numerous similitudes with spontaneous
epithelial mammary tumor cell lines (SEMTCL) described by
Santisteban et al. [20]. Noteworthy, Asclepios and SEMTCL shared
similar marker profile as both cell lines were CD24-negative
(Fig. 1J), CD34-negative (data not shown), CD44-positive (data not
shown), Sca1-negative (data not shown), E-cadherin-negative (data
not shown) and N-cadherin-positive (Fig. 2F).
Discussion
Bone marrow stromal cells (BMSC) are adult multipotent cells
that represent an attractive tool in strategies of cellular therapy.
Before in vivo use, BMSC have to be in vitro expanded in order to
Figure 8. Dendrogram from agglomerative hierarchical clustering of Asclepios and several cell types, including tumor cell lines.
Dendrogram generated after agglomerative hierarchical clustering using Euclidean distance, complete linkage and multiscale bootstrap resampling.
61 expression arrays were included in an unsupervised analysis with hierarchical clustering of samples. Spontaneous epithelial mammary tumor cell
lines (SEMTCL - GSE13259); Tumor cell lines 67NR, 66cl4 and 4T1 (TCL67NR, TCL66cl4 and TCL4T1 - GSE11259); Embryonal tumor deriving from neural
crest cells (NCCE85, NCCE135, NCCP90 - GSE11356); Multipotent adult progenitor cells (MAPC - GSE6291); Developing Heart (DH - GSE7196); Neural
precursors obtained from embryonic stem cells (NPFES - GSE8024); White and brown adipose (WAA, BAA - GSE8044); Head Neck Neural Crest Stem
Cells (E115FAKCtle1 - GSE11149); Murine acute myeloid leukemia (UAML - GSE30747). Datasets are accessible on GEO datasets/NCBI (http://www.
ncbi.nlm.nih.gov/gds). The dendrogram was built with the Euclidean distance as dissimilarity metric and the complete linkage method for definition
of the structure. Values on the edges of the clustering are p-values (%). Red values are AU p-values and green values are BP values. AU
(Approximately Unbiased) p-values were computed by multiscale bootstrap resampling. BP (Bootstrap Probability) values were computed by normal
bootstrap resampling. R-cran ‘‘pvclust’’ package was used for assessing the uncertainty of this hierarchical cluster analysis for 10,000 permutations of
genes. Those values indicated how strongly the cluster was supported by the data.
doi:10.1371/journal.pone.0046425.g008
Table 2. Cont.
Category Functions Annotation p-Value Regulation z-score
Cancer glioblastoma 1.14E203
Cancer sarcoma 1.32E203 20.413
Microarray comparison between Asclepios and neural crest stem cell clones
revealed 1,544 significant genes that were differentially expressed. Those genes
were introduced in IPA for biological functions and pathway analyses. The
results confirmed the tumor profile of Asclepios with cancer functions.
doi:10.1371/journal.pone.0046425.t002
Cell Transformation of Adult Bone Marrow NCSC
PLOS ONE | www.plosone.org 11 October 2012 | Volume 7 | Issue 10 | e46425
reach a suitable number of cells for their clinical applications [21].
Several years ago, numerous studies addressed the potential
danger of using MSC in cellular therapy. Indeed, it has been
shown that the in vitro manipulation of both human and murine
BMSC may alter the functional and biological properties of the
cells, leading to the accumulation of genetic alterations [9,22–26].
However, several laboratories did not confirm the propensity of
BMSC to develop morphological or genetic changes [21,27–28].
In light of these discrepant observations, it has been suggested that
phenotypic, functional and genetic assays, although known to have
limited sensitivity, should be routinely performed on MSC before
in vivo use to demonstrate whether their biological properties, after
ex vivo expansion, remain suitable for clinical application.
Similarly, a recent study showed that tumors obtained after
human polyomavirus JVC injection into mice bone marrow
stromal cells shared mesenchymal and neural crest characteristics
[29], suggesting that both cell types could induce tumors. As
BMSC are a mixed population containing both mesenchymal stem
cells (MSC) and neural crest stem cells (NCSC),, we more
specifically analyzed NCSC in this study. Indeed, 6 NCSC clones
were characterized in long-term culture process. One of those
clones (Asclepios) appeared to be tumorigenic as massive tumors
were observed after striatal injection. A closer look at the
transcriptomic level of Asclepios revealed strong modifications of
several cell cycle checkpoints. In normal cells, the cell cycle
checkpoints are carefully controlled by many factors. These
include, among others, the sequential activation and degradation
of the cellular cyclins (Cyclin D, A, B, and E), cyclin-dependent
kinases (CDKs; serine/threonine kinases) and their inhibitory
proteins cyclin-dependent kinase inhibitors (CDKIs, p15, p16 and
p21 families) [30–31]. Disturbance of cell cycle checkpoints could
lead to chromosome instability that can be actively involved in the
progression of cancers [32]. Here, we observed a strong down-
regulation of tumor suppressors such as p21 (a well-known cyclin-
dependant kinase inhibitor), p15 (that normally prevents the
activation of the CDK by inhibition of the cyclin D complex) and
NRG1, a major anti-proliferative gene [33]. One of the major
chromosomal modifications observed in Asclepios was located on
chromosome 11, as the long arm chromosome 11q was massively
down-expressed. Structural aberrations involving 11q are among
the most common aberrations in a number of cancers. Indeed,
chromosome 11q deletion has been characterized in a number of
cancers, including leukemia [18], pancreatic cancer [16], neuro-
blastoma [17] and breast cancer [34].
In this study, a dendrogram generated after agglomerative
hierarchical clustering comparing several transcriptomic data,
showed important similitudes between Asclepios and mammary
tumor cell lines. Transformations of BMSC into epithelial cancers
(including breast cancer) have already been reported [35], in that
study, they highlighted the fact that BMSC could contribute to
breast cancer after Epithelial-Mesenchymal Transition (EMT). In
breast cancer EMT is associated with increased aggressiveness,
invasiveness and metastasis [36]. However, it is still debated as to
whether EMT is an example of transdifferentiation of epithelial
cells to mesenchymal cells [37], or an expression of the
pluripotency of breast cancer stem cells [38]. In any case, EMT
represents a progression of breast cancer to a more malignant
phenotype, leading to expression of mesenchymal cells associated-
genes and behavior [12]. It is noteworthy that NCSC share many
phenotypic traits with classical BMSC [4], including expression of
numerous membrane markers, which in some cases could be
associated with EMT process.
One striking observation in this study is the fact that the tumoral
character of Asclepios was not suspected in vitro before grafting the
cells. However, a closer look at the proliferation rate of Asclepios
compared to the other clones revealed a significantly higher level
of proliferation after 48 hours, suggesting that proliferative activity
should be tested before any clinical use. Likewise, we show here
the existence of several modifications in the gene expression profile
of a tumorigenic clone that could also be checked before any
cellular therapy and thus, be regarded as indicators of a possible
tumoral transformation.
In conclusion, this study highlights the fact that NCSC isolated
from adult bone marrow may represent a potential danger for
cellular therapy, as in some restricted cases, NCSC can adopt a
tumorigenic phenotype, producing tumor in vivo. We then suggest
that phenotypic, functional and genetic assays should be
performed on NCSC (as it has already been suggested for MSC)
before in vivo use to demonstrate whether their biological
properties remain suitable for clinical applications.
Supporting Information
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